Journals LibraryNHS NIHR - National Institute for Health Research
HTA - 10/104/24
Safety and efficacy of Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke: the TARDIS randomised controlled trial
Project title: Safety and efficacy of Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke: the TARDIS randomised controlled trial
Call to action: 10/104 HTA Clinical Evaluation and Trials Open call
Research type: Primary Research
Contractor: The University of Nottingham
Co-investigators: Associate Professor Robert Dineen, Dr Chibeka Kasonde, Dr Graham Venables, Emeritus Professor Stan Heptinstall, Professor Hugh Markus, Professor Lelia Duley, Professor Marilyn James, Professor Nikola Sprigg, Professor Stuart Pocock, Professor Thompson Robinson.
Started: October 2012 | Status: Published September 2018
The incidence and severity of recurrent stroke or transient ischaemic attack did not differ between triple and guideline therapy.
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.